how many people use glp-1 drugs Agonists Weight Loss Market Report, 2025-2030 Impact of GLP-1 Drug Adoption

Description

Choosing the right one depends on your BMI, medical conditions, reflux history, diabetes status, eating patterns, prior surgery, medication use, and personal goals

However, despite previous reports on the potential advantage posed by GLP1-based multi-agonists in the management of obesity and metabolic disease, as recently exemplified by the dramatic body weight-lowering actions of the GLP1/GIP dual agonist, tirzepatide 47 , to our knowledge, no study has addressed to date the pharmacological characterization of GLP1-based unimolecular multi-agonists for management of reproductive and metabolic alterations of PCOS, using suitable preclinical models, as pre-requisite for their application in clinics

If you notice any shortness of breath or swelling around your face, tongue, or throat after using GLP-1s, stop using the medication immediately and contact emergency services right away